HomeNWBO • OTCMKTS
add
Northwest Biotherapeutics Inc
Previous close
$0.29
Day range
$0.28 - $0.29
Year range
$0.17 - $0.50
Market cap
416.93M USD
Avg Volume
5.42M
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 375.00K | 32.04% |
Operating expense | 9.34M | 15.45% |
Net income | -19.34M | -5.63% |
Net profit margin | -5.16K | 20.00% |
Earnings per share | — | — |
EBITDA | -16.88M | -10.19% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.78M | 12.15% |
Total assets | 27.50M | -3.72% |
Total liabilities | 112.34M | 36.94% |
Total equity | -84.84M | — |
Shares outstanding | 1.36B | — |
Price to book | -4.12 | — |
Return on assets | -159.60% | — |
Return on capital | 316.21% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -19.34M | -5.63% |
Cash from operations | -9.42M | 24.09% |
Cash from investing | -93.00K | 61.09% |
Cash from financing | 11.73M | -2.91% |
Net change in cash | 604.00K | 71.59% |
Free cash flow | -6.03M | -5.79% |
